Kuva Labs, Inc. acquires Lisata Therapeutics

Kuva Labs, Inc. agreed to acquire Lisata Therapeutics. Reported deal value: Undisclosed. Status: Pending. Sector: pharmaceutical. Target headquarters context: Basking Ridge, New Jersey, United States.

This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.

Lisata Therapeutics , Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that it has entered into a definitive agreement to be acquired by Kuva Labs Inc. , a privately-held company